Targeting mitochondrial biogenesis and function in Parkinson’s disease

Please note now WEDNESDAY July 19th

Dr. Deleidi group’s research aims to identify key molecular pathways in the pathogenesis of sporadic and familial Parkinson’s using human neurons derived from induced pluripotent stem cells (iPSCs).

Michela Deleidi is studying human ageing processes and age-related neurological disorders with a particular focus on Parkinson’s. She wants to employ stem cells from people affected by the condition and investigate how the immune system and mitochondria, the powerhouses of our cells, interact with each other. This should give more information about how inflammation in Parkinson’s plays a role in the development of the condition.